Home/Filings/4/A/0001213900-25-124535
4/A//SEC Filing

Bartushak Jaime 4/A

Accession 0001213900-25-124535

CIK 0001851484other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 4:10 PM ET

Size

5.3 KB

Accession

0001213900-25-124535

Insider Transaction Report

Form 4/AAmended
Period: 2025-09-19
Bartushak Jaime
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2025-09-19+825,000825,000 total
Footnotes (1)
  • [F1]Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

Issuer

CITIUS ONCOLOGY, INC.

CIK 0001851484

Entity typeother

Related Parties

1
  • filerCIK 0001725077

Filing Metadata

Form type
4/A
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:10 PM ET
Size
5.3 KB